jrnl3299

Publication Venue For

  • Chronobiological influence over cardiovascular function the good, the bad, and the ugly.  258-279. 2020
  • Race, Natriuretic Peptides, and High-Carbohydrate Challenge: A Clinical Trial.  125:957-968. 2019
  • Response by Pfeffer et al to Letter Regarding Article, "heart Failure with Preserved Ejection Fraction in Perspective".  125:E26. 2019
  • Heart Failure with Preserved Ejection Fraction in Perspective.  124:1598-1617. 2019
  • Treatment of Resistant and Refractory Hypertension.  124:1061-1070. 2019
  • Convergences of Life Sciences and Engineering in Understanding and Treating Heart Failure.  124:161-169. 2019
  • Lower blood pressure thresholds raise the bar in pregnancy.  125:195-197. 2019
  • Nuclear focal adhesion kinase controls vascular smooth muscle cell proliferation and neointimal hyperplasia through GATA4-mediated cyclin D1 transcription.  125:152-166. 2019
  • Lack of Remuscularization Following Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitor Cells in Infarcted Nonhuman Primates.  122:958-969. 2018
  • E2F1 suppresses oxidative metabolism and endothelial differentiation of bone marrow progenitor cells.  122:701-711. 2018
  • CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle.  122:88-96. 2018
  • Mitochondrial Reactive Oxygen Species in Lipotoxic Hearts Induce Post-Translational Modifications of AKAP121, DRP1, and OPA1 That Promote Mitochondrial Fission.  122:58-73. 2018
  • Can we engineer a human cardiac patch for therapy?.  123:244-265. 2018
  • Effective metabolic approaches for the energy starved failing heart: Bioenergetic resiliency via redundancy or something else?.  123:329-331. 2018
  • Global overview of the transnational alliance for regenerative therapies in cardiovascular syndromes (TACTICS) Recommendations: A comprehensive series of challenges and priorities of cardiovascular regenerative medicine.  122:199-201. 2018
  • Intra-cardiac release of extracellular vesicles shapes inflammation following myocardial infarction short communication.  123:100-106. 2018
  • Multifunctional role of chymase in acute and chronic tissue injury and remodeling.  122:319-336. 2018
  • Relationship between the efficacy of cardiac cell therapy and the inhibition of differentiation of human iPSC-Derived nonmyocyte cardiac cells into Myofibroblast-like cells.  123:1313-1325. 2018
  • Sprinting toward the optimal blood pressure target for hypertensive patients.  123:531-534. 2018
  • Transplanted mesenchymal stem cells reduce autophagic flux in infarcted hearts via the exosomal transfer of miR-125b.  123:564-578. 2018
  • PDK4 Inhibits Cardiac Pyruvate Oxidation in Late Pregnancy.  121:1370-1378. 2017
  • Meeting Report for the 2017 National Institutes of Health National Heart, Lung, and Blood Institute Progenitor Cell Biology Consortium: Cardiovascular Bioengineering Workshop and Symposium.  120:1709-1712. 2017
  • Immunomodulation is the key to cardiac repair.  120:1530-1532. 2017
  • Myocardial Tissue Engineering with Cells Derived from Human-Induced Pluripotent Stem Cells and a Native-Like, High-Resolution, 3-Dimensionally Printed Scaffold.  120:1318-1325. 2017
  • Elevating CXCR7 Improves Angiogenic Function of EPCs via Akt/GSK-3β/Fyn-Mediated Nrf2 Activation in Diabetic Limb Ischemia.  120:e7-e23. 2017
  • Reprogrammed Human Endothelial Cells.  120:756-758. 2017
  • From Microscale Devices to 3D Printing: Advances in Fabrication of 3D Cardiovascular Tissues.  120:150-165. 2017
  • A special report on the NHLBI initiative to study cellular and molecular mechanisms of arterial stiffness and its association with hypertension.  121:1216-1218. 2017
  • Lactate promotes synthetic phenotype in vascular smooth muscle cells.  121:1251-1262. 2017
  • Crossing into the Next Frontier of Cardiac Extracellular Matrix Research.  119:1040-1045. 2016
  • Meeting Report for NIH 2016 Progenitor Cell Biology Consortium Cardiovascular Tissue Engineering 2016.  119:981-983. 2016
  • Response by Zhou et al to Letter Regarding Article, Loss of Adult Cardiac Myocyte GSK-3 Leads to Mitotic Catastrophe Resulting in Fatal Dilated Cardiomyopathy.  119:e29-e30. 2016
  • The biological basis for cardiac repair after myocardial infarction.  119:91-112. 2016
  • Assessing Cardiac Metabolism.  118:1659-1701. 2016
  • Loss of adult cardiac myocyte GSK-3 leads to mitotic catastrophe resulting in fatal dilated cardiomyopathy.  118:1208-1222. 2016
  • Long-Term Outcome of Administration of c-kitPOS Cardiac Progenitor Cells after Acute Myocardial Infarction: Transplanted Cells Do not Become Cardiomyocytes, but Structural and Functional Improvement and Proliferation of Endogenous Cells Persist for at Least One Year.  118:1091-1105. 2016
  • A large-scale investigation of hypoxia-preconditioned allogeneic mesenchymal stem cells for myocardial repair in nonhuman primates: Paracrine activity without remuscularization.  118:970-983. 2016
  • CDKN2B Regulates TGFβ Signaling and Smooth Muscle Cell Investment of Hypoxic Neovessels..  118:230-240. 2016
  • The Nervous Heart.  117:980-981. 2015
  • Abstract 221: Chronic Alterations of the Tissue Dendritic Cell and Macrophage Network Underlies the Th1 Response in the Failing Heart.  111:A221. 2015
  • Abstract 90: The Spleen Is an Essential Regulator of Systemic Neovascularization In Vivo.  111:A90. 2015
  • Genetic Deficiency of Glutathione S-Transferase P Increases Myocardial Sensitivity to Ischemia-Reperfusion Injury.  117:437-449. 2015
  • Bach1 represses Wnt/β-catenin signaling and angiogenesis.  117:364-375. 2015
  • Embryonic Stem Cell-Derived Exosomes Promote Endogenous Repair Mechanisms and Enhance Cardiac Function Following Myocardial Infarction.  117:52-64. 2015
  • New Approaches in the Treatment of Hypertension.  116:1074-1095. 2015
  • The GSK-3 family as therapeutic target for myocardial diseases.  116:138-149. 2015
  • Abstract 60: The Role of Mononuclear Phagocytes in Pressure Overload Heart Failure.  115:A60. 2014
  • PGC-1α induces SPP1 to activate macrophages and orchestrate functional angiogenesis in skeletal muscle.  115:504-517. 2014
  • OxLDL Triggers Retrograde Translocation of Arginase2 in Aortic Endothelial Cells via ROCK and Mitochondrial Processing Peptidase.  115:450-459. 2014
  • Sorafenib cardiotoxicity increases mortality after myocardial infarction.  114:1700-1712. 2014
  • Activation of AKT by O-linked N-Acetylglucosamine induces vascular calcification in diabetes mellitus.  114:1094-1102. 2014
  • It takes two to tango: Monocyte and macrophage duality in the infarcted heart.  114:1558-1560. 2014
  • Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure critical importance of the cardiosplenic axis.  114:266-282. 2014
  • Patching the heart: Cardiac repair from within and outside.  113:922-932. 2013
  • Overexpression of endothelial nitric oxide synthase prevents diet-induced obesity and regulates adipocyte phenotype.  111:1176-1189. 2012
  • Metabolic remodeling in the hypertrophic heart: Fuel for thought.  111:666-668. 2012
  • Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification.  111:543-552. 2012
  • Bioenergetic and functional consequences of cellular therapy: Activation of endogenous Cardiovascular progenitor cells.  111:455-468. 2012
  • Enhanced angiogenic and cardiomyocyte differentiation capacity of epigenetically reprogrammed mouse and human endothelial progenitor cells augments their efficacy for ischemic myocardial repair.  111:180-190. 2012
  • Orai1 determines calcium selectivity of an endogenous trpc heterotetramer channel.  110:1435-1444. 2012
  • Elucidating nature's solutions to heart, lung, and blood diseases and sleep disorders.  110:915-921. 2012
  • Inhalation of nitric oxide prevents ischemic brain damage in experimental stroke by selective dilatation of collateral arterioles.  110:727-738. 2012
  • Response to the letter by Edwards et al.  110. 2012
  • Animal models of heart failure a scientific statement from the American Heart Association.  111:131-150. 2012
  • Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels.  109:1259-1268. 2011
  • Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium.  109:1280-1289. 2011
  • PGC-1β deficiency accelerates the transition to heart failure in pressure overload hypertrophy.  109:783-793. 2011
  • Translational success stories: Angiotensin receptor 1 antagonists in heart failure.  109:437-452. 2011
  • Lack of primary cilia primes shear-induced endothelial-to-mesenchymal transition.  108:1093-1101. 2011
  • ATP production rate via creatine kinase or ATP synthase in Vivo: A novel superfast magnetization saturation transfer method.  108:653-663. 2011
  • Sustained hemodynamic stress disrupts normal circadian rhythms in calcineurin-dependent signaling and protein phosphorylation in the heart.  108:437-445. 2011
  • Genetic variation in NCAM1 contributes to left ventricular wall thickness in hypertensive families.  108:279-283. 2011
  • Late-breaking basic science abstracts from the American Heart Association's Scientific Sessions 2010.  107. 2010
  • PGC-1 coactivators in cardiac development and disease.  107:825-838. 2010
  • Increased endothelial exocytosis and generation of endothelin-1 contributes to constriction of aged arteries.  107:242-251. 2010
  • Preferential oxidation of triacylglyceride-derived fatty acids in heart is augmented by the nuclear receptor PPARα.  107:233-241. 2010
  • Decreased S-nitrosylation of tissue transglutaminase contributes to age-related increases in vascular stiffness.  107:117-125. 2010
  • Glycogen synthase kinase-3β regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivo.  106:1635-1645. 2010
  • Peroxisome proliferator-activated receptor δ is an essential transcriptional regulator for mitochondrial protection and biogenesis in adult heart.  106:911-919. 2010
  • Career moves: Induced pluripotent cells from human aortic smooth muscle cells can efficiently redifferentiate into parental phenotype.  106:7-9. 2010
  • Nitro-fatty acid inhibition of neointima formation after endoluminal vessel injury.  105:965-972. 2009
  • Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation.  105:897-905. 2009
  • Direct Relationship Between Protein O-GlcNAcylation and the Cardiomyocyte Circadian Clock.  105:E50-E50. 2009
  • Increased Cardiomyocyte 0-linked-beta-N-acetylglucosamine (0-GlcNAc) Levels Induced by Glucose Deprivation Mediated by Decreased 0-GlcNAcase Expression and Reduced Hexosamine Biosynthesis Flux.  105:E34-E35. 2009
  • O-linked-beta-N-acetylglucosamine (O-GlcNAc) Mediated Ischemic Cardioprotection Associated with Increased O-GlcNAcylation of Cytoskeletal Z-Line Proteins.  105:E13-E13. 2009
  • Inducible Expression of Active Protein Phosphatase-1 Inhibitor-1 Enhances Basal Cardiac Function and Protects Against Ischemia/Reperfusion Injury.  104:1012-1020. 2009
  • IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR.  104. 2009
  • Unique hexosaminidase reduces metabolic survival signal and sensitizes cardiac myocytes to hypoxia/reoxygenation injury.  104:41-49. 2009
  • Cell-free embryonic stem cell extract-mediated derivation of multipotent stem cells from NIH3T3 fibroblasts for functional and anatomical ischemic tissue repair.  102. 2008
  • Endothelial arginase II: A novel target for the treatment of atherosclerosis.  102:923-932. 2008
  • Negative-feedback loop attenuates hydrostatic lung edema via a cGMP-dependent regulation of transient receptor potential vanilloid 4.  102:966-974. 2008
  • Atrial natriuretic peptide inhibits transforming growth factor β-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts.  102:185-192. 2008
  • Role of mitochondrial dysfunction in insulin resistance.  102:401-414. 2008
  • Heme-Egr-1: New partners in atherosclerotic progression?.  102:6-8. 2008
  • Inducible NO synthase-dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction.  101:692-702. 2007
  • Myocardial Smad4 is essential for cardiogenesis in mouse embryos.  101:277-285. 2007
  • Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis.  100:1703-1711. 2007
  • Alternative splicing of ryanodine receptors modulates cardiomyocyte Ca2+ signaling and susceptibility to apoptosis.  100:874-883. 2007
  • Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration.  100:654-661. 2007
  • Myocyte nitroso-redox imbalance in sepsis: NO simple answer.  100:1-4. 2007
  • The role of O-GlcNAcylation in aging-related loss of estrogenic vasoprotection.  99:1282-1282. 2006
  • APOE4-VLDL inhibits the HDL-activated phosphatidylinositol 3-kinase/Akt pathway via the phosphoinositol phosphatase SHIP2.  99:829-836. 2006
  • Free radicals, mitochondria, and oxidized lipids: The emerging role in signal transduction in vascular cells.  99:924-932. 2006
  • Oxidized low-density lipoprotein-dependent endothelial arginase II activation contributes to impaired nitric oxide signaling.  99:951-960. 2006
  • Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function.  98:1098-1105. 2006
  • Coupled and uncoupled NOS: Separate but equal? Uncoupled NOS in endothelial cells is a critical pathway for intracellular signaling.  98:717-719. 2006
  • Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity.  98:119-124. 2006
  • Activation of the endothelial store-operated ISOC Ca 2+ channel requires interaction of protein 4.1 with TRPC4.  97:1164-1172. 2005
  • An apolipoprotein A-I mimetic works best in the presence of apolipoprotein A-I.  97:1085-1086. 2005
  • Oral small peptides render HDL antiinflammatory in mice and monkeys and reduce atherosclerosis in ApoE null mice.  97:524-532. 2005
  • Inhibition of lipopolysaccharide-induced inflammatory responses by an apolipoprotein AI mimetic peptide.  97:236-243. 2005
  • Glucosamine-induced cardioprotection mediated by the hexosamine biosynthesis pathway and increased levels of O-linked N-acetylglucosamine on nucleocytoplasmic proteins.  97:E28-E28. 2005
  • Essential role of a Ca2+-selective, store-operated current (ISOC) in endothelial cell permeability determinants of the vascular leak site.  96:856-863. 2005
  • Low-voltage-activated (T-type) calcium channels control proliferation of human pulmonary artery myocytes.  96:864-872. 2005
  • Increased PI3-kinase in presympathetic brain areas of the spontaneously hypertensive rat.  96:277-279. 2005
  • Cytokine-induced modulation of cardiac function.  95:1140-1153. 2004
  • Apurinic/apyrmidinic endonuclease 1 regulates endothelial NO production and vascular tone.  95:902-910. 2004
  • Antiinflammatory properties of HDL.  95:764-772. 2004
  • How do red blood cells dilate blood vessels?--Reply..  95. 2004
  • Effects of electrical shocks on Cai2+ and V m in myocyte cultures.  94:1589-1597. 2004
  • Nitric oxide protects against pathological ventricular remodeling: Reconsideration of the role of NO in the failing heart.  94:1155-1157. 2004
  • Upregulation of Alveolar Epithelial Active Na+ Transport Is Dependent on β2-Adrenergic Receptor Signaling.  94:1091-1100. 2004
  • Genome-Wide Scan Identifies Novel QTLs for Cholesterol and LDL Levels in F2[Dahl RxS] Intercross Rats.  94:446-452. 2004
  • Nonlinear Changes of Transmembrane Potential, during Electrical Shocks: Role of Membrane Electroporation.  94:208-214. 2004
  • CaV3.1 (α1G) T-type Ca2+ channels mediate vaso-occlusion of sickled erythrocytes in lung microcirculation.  93:346-353. 2003
  • Nitric oxide regulation of myocardial contractility and calcium cycling: Independent impact of neuronal and endothelial nitric oxide synthases.  92:1322-1329. 2003
  • Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyclooxygenase-2-dependent mechanism.  92:741-748. 2003
  • Sustained reentry in the left ventricle of fibrillating pig hearts.  92:539-545. 2003
  • Vectorial sodium transport across the mammalian alveolar epithelium: It occurs but through which cells?.  92:348-349. 2003
  • Regional differences in ventricular fibrillation in the open-chest porcine left ventricle.  91:733-740. 2002
  • Effects of S-nitrosation and cross-linking of hemoglobin on hypoxic pulmonary vasoconstriction in isolated rat lungs.  91:626-632. 2002
  • Gene dosage-dependent effects of cardiac-specific overexpression of the A3 adenosine receptor.  91:165-172. 2002
  • Optical mapping of arrhythmias induced by strong electrical shocks in myocyte cultures.  90:664-670. 2002
  • Recent fibrillation studies: Attempts to wrest order from disorder.  89:1089-1091. 2001
  • Nitric oxide synthase (NOS2) mutation in Dahl/Rapp rats decreases enzyme stability.  89:317-322. 2001
  • Autonomous and growth factor - Induced hypertrophy in cultured neonatal mouse cardiac myocytes: Comparison with rat.  87:781-788. 2000
  • Nonlinear changes of transmembrane potential during defibrillation shocks: Role of Ca2+ current.  87:453-459. 2000
  • Hydrogen peroxide- and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells.  86:960-966. 2000
  • Fibrillating myocardium: Rabbit warren or beehive?.  86:369-370. 2000
  • Identification of cis Elements in the Cardiac Troponin T Gene Conferring Specific Expression in Cardiac Muscle of Transgenic Mice.  86:478-484. 2000
  • The angiotensin II-dependent association of Jak2 and c-Src requires the N-terminus of Jak2 and the SH2 domain of c-Src.  84:1332-1338. 1999
  • Chemiluminescent detection of oxidants in vascular tissue: Lucigenin but not coelenterazine enhances superoxide formation.  84:1203-1211. 1999
  • Incidence, evolution, and spatial distribution of functional reentry during ventricular fibrillation in pigs.  84:945-954. 1999
  • Spatial changes in the transmembrane potential during extracellular electric stimulation.  83:1003-1014. 1998
  • Importance of E-selectin for firm leukocyte adhesion in vivo.  83:287-294. 1998
  • ATP-sensitive K+ channels, adenosine, and nitric oxide-mediated mechanisms account for coronary vasodilation during exercise.  82:346-359. 1998
  • Activation of cardiac tissue by extracellular electrical shocks: Formation of 'secondary sources' at intercellular clefts in monolayers of cultured myocytes.  82:375-385. 1998
  • Cyclic GMP-dependent protein kinase inhibits osteopontin and thrombospondin production in rat aortic smooth muscle cells.  82:139-146. 1998
  • Cross talk between angiotensin AT1 and α1-adrenergic receptors: Angiotensin II downregulates α(1a)-adrenergic receptor subtype mRNA and density in neonatal rat cardiac myocytes.  81:396-403. 1997
  • Anisotropic Activation Spread in Heart Cell Monolayers Assessed by High-Resolution Optical Mapping: Role of Tissue Discontinuities.  79:115-127. 1996
  • Functional and structural assessment of intercellular communication: Increased conduction velocity and enhanced connexin expression in dibutyryl cAMP-treated cultured cardiac myocytes.  79:174-183. 1996
  • Spatial changes in transmembrane potential during extracellular electrical shocks in cultured monolayers of neonatal rat ventricular myocytes.  79:676-690. 1996
  • 23Na and 31P nuclear magnetic resonance studies of ischemia-induced ventricular fibrillation. Alterations of intracellular Na+ and cellular energy..  77:394-406. 1995
  • Formation of F2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite.  77:335-341. 1995
  • Altered pulmonary microvascular reactivity to norepinephrine in canine pacing-induced heart failure..  75:347-356. 1994
  • Anisotropic conduction in monolayers of neonatal rat heart cells cultured on collagen substrate.  75:591-595. 1994
  • Cloning of the rat α(1C)-adrenergic receptor from cardiac myocytes: α(1C), α(1B), and α(1D) mRNAs are present in cardiac myocytes but not in cardiac fibroblasts.  75:796-802. 1994
  • Computer simulations of three-dimensional propagation in ventricular myocardium: Effects of intramural fiber rotation and inhomogeneous conductivity on epicardial activation.  72:744-756. 1993
  • Coronary pressure-flow relation in left ventricular hypertrophy: Importance of changes in back pressure versus changes in minimum resistance.  72:579-587. 1993
  • Microscopic conduction in cultured strands of neonatal rat heart cells measured with voltage-sensitive dyes.  73:914-925. 1993
  • Kinetics of restitution of left ventricular relaxation.  70:29-38. 1992
  • Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial, and M cells.  69:1427-1449. 1991
  • Correlation between transmural high energy phosphate levels and myocardial blood flow in the presence of graded coronary stenosis.  67:660-673. 1990
  • Differences in myosin isoform expression in the subepicardial and subendocardial myocardium during cardiac hypertrophy in the rat.  66:1127-1132. 1990
  • Differences in the electrophysiological response to canine ventricular subendocardium and subepicardium to acetylcholine and isoproterenol. A direct effect of acetylcholine in ventricular myocardium.  67:615-627. 1990
  • Increased ischemic injury but decreased hypoxic injury in hypertrophied rat hearts.  67:948-959. 1990
  • Morphological development of the rat heart growing in oculo in the absence of hemodynamic work load.  66:84-102. 1990
  • Vagally induced block and delayed conduction as a mechanism for circus movement tachycardia in frog atria.  64:213-226. 1989
  • Vascular remodeling and improvement of coronary reserve after hydralazine treatment in spontaneously hypertensive rats.  64:1127-1136. 1989
  • Transient outward current prominent in canine ventricular epicardium but not endocardium.  62:116-126. 1988
  • Sympathetic innervation alters growth and intrinsic heart rate of fetal rat atria maturing in oculo.  59:534-544. 1986
  • Histamine H1 receptor antagonists inhibit autoregulation of renal blood flow in the dog.  54:527-535. 1984
  • Effect of acute hypoxia on the pulmonary conversion of angiotensin I to angiotensin II in dogs.  46:221-226. 1980
  • Autoregulatory responses of superficial nephrons and their association with sodium excretion during arterial pressure alterations in the dog.  41:487-496. 1977
  • Development of left ventricular hypertrophy in young spontaneously hypertensive rats after peripheral sympathectomy.  40:428-434. 1977
  • Relation of renal hemodynamics to metabolism of angiotensin II by the canine kidney.  41:283-287. 1977
  • Structural requirements for substrates and inhibitors of angiotensin I converting enzyme in vivo and in vitro.  34:19-26. 1974
  • Mechanism of renal handling of angiotensin II in the dog.  33:500-507. 1973
  • Substrate requirements for angiotensin I conversion in vivo and in vitro..  32:415-423. 1973
  • Mechanism of pulmonary conversion of angiotensin I to angiotensin II in the dog..  29:682-690. 1971
  • In-vivo and in-vitro conversion of angiotensin I to angiotensin II in dog blood..  26:591-599. 1970